Author:
Dume Roberta,Shuman Michael
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Orthopedics and Sports Medicine
Reference17 articles.
1. Pharmacometric modeling of naloxegol efficacy and safety: Impact on dose and label;Al-Huniti;Clinical Pharmacology and Therapeutics,2017
2. The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol;Bui;Journal of Clinical Pharmacology,2014a
3. The effects of renal impairment on the pharmacokinetics, safety, and tolerability of naloxegol;Bui;Journal of Clinical Pharmacology,2014b
4. The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol;Bui;Journal of Clinical Pharmacology,2016
5. Effects of CYP3A modulators on the pharmacokinetics of naloxegol;Bui;Journal of Clinical Pharmacology,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献